Skip to main content
. 2018 Oct 12;224(1):293–314. doi: 10.1007/s00429-018-1771-5

Table 3.

List of the antibodies and the antisera that were used in the experiments

Antibody Antigen Source Species Dilution
PV235 Purified carp parvalbumin Swant Inc., Marly, Switzerland Mouse monoclonal
Lot 10-11F
1:1000–5000
PV25 Recombinant rat parvalbumin Swant Inc., Marly, Switzerland Rabbit polyclonal
Lot 5.10
1:1000–1:5000
GP72 Recombinant mouse parvalbumin Swant Inc., Marly, Switzerland Guinea pig polyclonal 1:1000–1:5000
PVG213/214 Recombinant rat parvalbumin Swant Inc., Marly, Switzerland Goat polyclonal 1:1000
GFP Recombinant peptide Molecular Probes, Waltham, (USA) Rabbit polyclonal 1:3000
5-HT Serotonin Immunonuclear Rabbit polyclonal 1:2000
TH Tyrosine-hydroxylase Immunostar, Stillwater (USA) Rabbit polyclonal 1:10,000
SMI-32 Non-phosphorylated filaments Millipore, USA Mouse monoclonal 1:1000
VGlut 1 Recombinant peptide Synaptic System, Germany Rabbit or mouse 1:5000/1:20,000
VGlut 2 Recombinant peptide Synaptic System, Germany Rabbit 1:10,000
GAD Recombinant peptide Millipore, USA Mouse 1:2000

The antibodies against Parv were utilized primarily to confirm that the endings from the OFC did indeed impinge on parvalbumin-immunoreactive neurons in the parvafox nucleus. The serotonin- and TH-antisera helped to define the borders of the raphe and the coeruleus nuclei. GFP-antisera served to enhance the fluorescence in the terminals of the brainstem and the spinal cord